US Patent 9284365 Anti-hemagglutinin antibodies and methods of use
Patent 9284365 was granted and assigned to Genentech on March, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 4 Dec, 2023
Golden AI
Edits made to:
Article (+162 characters)
Article
Patent abstract
The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Gerald R. Nakamura0
Henry Chiu0
Hyunjoo Park0
Lee Swem0
Mercedesz Balazs0
Min Xu0
Nancy Chiang0
Ning Chai0
Patrick Lupardus0
Zhonghua Lin0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09284365 Anti-hemagglutinin antibodies and methods of use US Patent 9284365 Anti-hemagglutinin antibodies and methods of use
Infobox
Patent Number
092843650
Patent Number
92843650
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
092843650
Date of Patent
March 15, 2016
0Patent Application Number
140774140
Date Filed
November 12, 2013
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09284365 Anti-hemagglutinin antibodies and methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09284365
Date of patent
March 15, 2016
Patent application number
14077414
Date Filed
November 12, 2013
Patent primary examiner
Find more entities like US Patent 9284365 Anti-hemagglutinin antibodies and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
